Conference Information

Welcome Message

Pulsus welcomes you to join us at the “6^th European virtual summit on Pharmaceutical science 2022” on February 11-12, 2022, hosted by a committee of organizers and management in collaboration with academics and businessmen. This year European Pharma 2022 is based on “Healing the past with the future of Pharmaceutical science”.

The theme of the event is to explore a unique opportunity to work with world-class researchers in organizations, universities, and businesses, and active people overseas.Poster exhibitions and video presentations and marketing discussions for your industry ideas, and new research materials.

Explore and learn about Pharmaceutical Sciences, making your participation from various countries and sharing their views and ideas in European Pharma 2022.

If you have any questions you can drop us an email at europharmacongress@pulsusseries.com
Connect and Explore !!!
With Support & Regards,
European Pharma 2022

About Conference

Pulsus Group is an internationally renowned peer-review publisher in scientific, technical, and medical journals established in the year 1984 with offices in Ontario, Canada and Hyderabad, India publishes and hosts the work of researchers in a manner that exemplifies the highest standards in research integrity. With a legacy of 30 years of excellence in Medical Publishing, Now, we are running several International Conferences in the fields of Medical, Clinical, Life Science and, Pharma.

Pulsus through its cmesociety.com is been very instrumental to provide an invaluable channel for scientists and researchers to exchange ideas and research by creating a forum for discussing the possibilities of future collaborations between universities, institutions, research bodies and organizations from different countries through international CME/CPD accredited conferences and meetings.

Why you should participate?

Be the person to connect with the variety of the Global Drug Market. Integrate new environmental activities from multiple speakers, poster presentations and work plans by encouraging them to promote business leadership in Pharmaceutical.

Meet with Pharmacologists
Improve the learning of new tips and tricks
Certificates
Show your Works
Check Healthcare Programs and Development
Product Centre

Why Pharmaceutical Sciences 2022?

The founders of Pharmaceutical Science and Health Care Professionals end up as world pioneers in the COVID-19 epidemic. Pharmaceutical Sciences emerged as an interest between the pharmaceutical industry and public health research organizations.

The Pharma Sector contains the design of antibiotics, therapeutic solutions, traditional drugs, nutraceuticals, cosmeceuticals, immune-oncology vaccines, tissue engineering and regenerative medicine, prophylaxis of diseases, preventive health care, new predictive solutions, products On going -bio, and genome-based diagnoses and research solutions. Spending on health care has empowered the principles found in drug discovery in clinical trials, in clinical trials, in the development of biomedical applications for diagnostics and treatment in the industrial, commercial and manufacturing industries.

Tracks

Track 1: Pharmaceutical Industry:

Pharmaceutical revenues are created as a result of their therapeutic demand objectives for public health. They confront substantial problems in terms of increased or decreased demand for blockbuster pharmaceuticals, unforeseen changes in dynamic care, generating fresh original concepts, managing consolidation and rivalry across sectors, and so on. In 2019, the pharmaceutical sector is worth a total of 1.25 trillion US dollars. The pharmaceutical business is concerned with the research, research, and production of drugs and treatments by both public and commercial entities. The pharmaceutical industry's continuous growth and progress are critical to the global control and elimination of illness.

Track 2: Therapeutics Research:

Therapeutics Research operates commercially successful and impressive growth in productive change for research and development as well as industrial revenue. The biotech industry is thriving in such a way, that has dramatically changed the boring growth of drug regulation and validation into a faster and faster process. It aims to focus on R&D and innovation in health science software. The market size of biotechnology is estimated at 752.88 billion USD by 2020 and is expected to increase 15.83% annually from 2021 to 2028, with the expansion of the development and management of several global risks.

Track 3: Drug Formulations and Development:

Clinical preliminaries provide a powerful way to tackle drug improvements and ideas for the exchange of information between the safety and complexity of new diseases. This process is associated with the identification of candidates, word combinations, rating, verification, validity, testing, and evaluation of clinical performance. The composition of the invention is a key element now and in the future of medical research. To date, more than 500,000 prescription drugs have been developed.

Track 4: Computational biology:

Major advances in research methods and bioinformatics research programs have allowed us to deal with problems such as the timing of drug discovery, the epidemic of serious and difficult effects, and new biological mysteries. Data stores and powerful algorithms have been useful tools for researchers trying to understand complex biological systems, establishing nucleotide and protein sequences, or duplicating the process of evolution. Computer bio-molecular systems will affect our lives in much the same way as electronic devices work.

Track 5: Bio-Medical Technology:

Biomedical research is a large field of science that investigates biological processes and diseases caused by total experimentation, observation, laboratory work, analysis, and testing. Evidence-based medicine systematic testing, testing, and use of clinical research results to assist in the delivery of quality clinical care to patients. Biomedical research is important in understanding and continuing clinical research and related areas. Given the importance of human health and the many medical and clinical complications that can result, biomedical research is extremely important.

Track 6: Technology Advances in Life Science:

The creation of a sophisticated database in pharmaceutical sciences set the path for dealing with the complex organizational landscape of pharmaceutical. The collaboration among several life sciences businesses leads to advancements in pharmaceutical research. This increasing number of life science researchers has created new chances for developing goods to better the lives of organisms and investigating potential in the pharmaceutical business. By 2027, the life science industry is anticipated to be worth around US$ 95.68 billion. Cancer biomarkers are expected to have a market value of $26,979.50 million by 2027, with a CAGR

Track 7: Health Care Worker Challenges:

The most serious health challenges are under the watchful eye of researchers and medical professionals. For health workers, the past year has been an unbearable one. This has created a difficult situation about overcoming the current and high-quality care management capacity of all patients. Understanding illness, supporting poor patients, and reducing the spread of the disease are important challenges for health care workers, and they have a responsibility to ensure and achieve a well-distributed immune system in patients. Medical professionals make all the decisions regarding medical examinations, and they produce results to evaluate the results.

Track 8: Future Toxicology Analyses:

The basic principles, assumptions, and explanations associated with the effects of chemical exposure, dosage, and toxicity at risk, as well as the importance of animal experiments in predicting chemical effects in humans, are focused on toxicology. Toxicokinetics is the term for the study of all compounds kinetics with toxic doses and limits of exposure. Recent reviews of the study indicate that significant progress should be expected in the field of pharmacokinetics and toxicokinetics to evaluate drug interactions and drug interactions with dietary drugs. As part of a non-clinical trial of pharmaceutical drugs, animal toxicology tests were performed prior to and in collaboration with human clinical research. The xenobiotic response to the toxicity test has been studied. The toxic effects of chemicals or other substances on various substances at different rates contribute to environmental hazards.

Track 9: Pharmaceutical Pricing:

The rapid development of pharmaceutical drugs has necessitated the rapid growth of export-oriented drugs and drugs. Investment in research production and pharmaceutical production is integrated into the network of suppliers and stock exchanges. Drug prices are subject to less environmental control, which is causing changes in the pharmaceutical sector. The risk of obtaining evidence of caution has ensured that the drugs are used properly.

Track 10: Pharmacology and medicinal chemistry:

The need for access to drugs has prompted action to eradicate emerging diseases. However, these developments protect public health through other problems and environmental degradation. Medical warnings to protect patients, as well as to study the side effects of medications or diagnoses, or other non-medical items, have become a priority in health care. Concerns about emerging risks and development debates include negative global trends. These situations must be taken into account, and the authorities must provide remedies from abroad.

Track 11: Pre-Clinical and Clinical Trials:

Specialists in pre-clinical and clinical trials have become standard scientific standards for evaluating global therapeutic solutions. The pre-clinical trial focuses on major aspects of the diagnosis and validation of 'Drug and Target', while the Clinical Trial focuses on the type of medication and monitoring of global health. The process of drug discovery involves identifying the appropriate target molecule or protein receptor that is directly related to the disease or disease status. Treatment may be medical, medical, or biological, such as vaccines, blood products, or genetic therapies.

Track 12: Bio-pharmaceutics and Clinical Pharmacokinetics:

Biopharmaceutics and Clinical Pharmacokinetics has revolutionized the field of drug manufacturing and further development during the public health challenge. Pre-clinical research of micro-organisms and animals, filing control conditions, according to the US Food and Drug Administration, on a new investigative drug to initiate clinical trials in humans, and could include the process of obtaining regulatory approval for a new drug program to market. The Biopharmaceutics market aims to grow its average annual growth by 8.3% from 2018 to 2025, with a growing sector of 3,000 Pharma companies and extensive research institutes.

Track 13: Pharmaceutical entrepreneur:

Entrepreneurs inculcate innovation in pharmaceuticals and create business ideas to an extreme degree. They were caught with a high risk of planning, good decisions, and great advisors in the establishment of Pharmaceuticals. This impact leads to the growth of a broader business perspective in the field of proteomics, genomics, and surveillance. Business is the most direct way of building from university to industry. A scientist makes an idea, invented something, and then shares it with the rest of the world for a profit. This is why a bio-entrepreneur has a lot of data, and having more knowledge about his product makes identifying and solving problems easier.

Track 14: Global Artificial Intelligence in Pharmaceutical:

The development of computer technology basically requires human ingenuity to perform pre-tasks. It is a machine learning process that includes tasks such as an algorithm for mathematical concepts, visual acuity, tracking, analytics, translation, and speech recognition. The application of Artificial Intelligence in health care includes individual safety considerations, diagnoses and treatments, changing people's approaches to their health needs. Gain trustworthy. However, Artificial Intelligence startups will have a limited job loss of long-term health functions. It is suggested that 35% of UK jobs will be demolished by the presence of Artificial Intelligence, in the next 10 to 20 years. In the science of life, even though Artificial Intelligence achieves a reliable result, in some cases its algorithm methods do not work in solving experimental and error methods.

Track 15: Pharmacognosy and Plant Biochemistry:

The use of plants as a source of medicine has been inherited and is an integral part of the health care system. Major advances in the field of chemical and biological analysis have transformed research into pharmacognosy. Pharmacognosy research areas continue to expand, and now include cellular features and molecular biology in relation to natural products, as well as phytotherapy, in addition to the development of traditional methods of analysis and photochemistry. Molecular Pharmacognosy, Genomic Pharmacognosy, and Metabolomic Pharmacognosy are considered promising approaches to Pharmacognosy research to address future needs in molecular biology, biotechnology, and analytical chemistry.

Track 16 : Social Pharmacology

Social Pharmacology is area of health technological know-how which generates understanding approximately marketed pills in actual use. it makes a speciality of assessment of the social effects of an individual’s publicity to any advertised drug and factors associated with its utilization. The purpose of this subject is to benefit understanding nonetheless wanted after a drug is advertised.

Highlights of the Conference :

1. Pharmaceutical Industry

2. Therapeutics Research

3. Drug Formulations and Development

4. Computational biology

5. Bio-Medical Technology

6. Technology Advances in Life Science

7. Health Care Worker Challenges

8. Future Toxicology Analyses

9. Pharmaceutical Pricing

10. Pharmacology and medicinal chemistry.

11. Pre-Clinical and Clinical Trials.

12. Bio-pharmaceutics and Clinical Pharmacokinetics.

13. Pharmaceutical entrepreneur.

14. Global Artificial Intelligence in Pharmaceutical

15. Pharmacognosy and Plant Biochemistry.

16. Social Pharmacology

Market Analysis of Pharma

Market Analysis of Pharmaceuticals

In 2018, the USA represented the most important pharmaceutical marketplace globally with a marketplace length of $ 490.8 billion U.S. China became the subsequent marketplace via way of means of length, producing over $ 230 billion with inside the identical year.

Pharmaceuticals companies have excelled in a variety of cell treatments, clinical research, biomedicine, health science software, clinical testing software, vector-based technologies, bio-reagents, synthetic proteins, antibodies and medical device industries.

Pharmacists have invested more than € 1.2 billion in co-operative development in pharmaceutical or biotechnology companies with finished or out dated products (Phase II b / III) of clinical trials, Pharmacovigilance to the Bio- Pharmaceuticals, in the field of, nutraceuticals, cosmeceuticals , environmental health, animal health industry, where opportunities exist through R&D projects, commerce, technology transfer, collaborative development and licensing.

Closely tied to the healthcare enterprise, the pharmaceutical enterprise is likewise dealing with challenges, together with stress on drug pricing, regulation, converting healthcare models, and the increase of worldwide drug production and sales. By 2024 the worldwide pharmaceutical marketplace is expected to develop to over US $1.3 trillion, with a CAGR of almost 7%, and $500 billion with inside the U.S. alone.

Related Companies:

Pfizer
Merck and Co
Johnson and Johnson
Baxter
Boehringer
Cyclomedica Europe Ltd.
Ingelheim

Related Universities in pharmacy:

Harvard University, US.
University of Cambridge, UK.
National University of Singapore, Singapore.
University of Oxford, UK.
Karolinska Institute, Sweden.
University College London (UCL), UK.
Imperial College London, UK.

Related organization:

Pharmaceutical Group of the European Union (PGEU)
European Pharmaceutical Union (EPU)
International Pharmaceutical Federation (FIP)
European Association of Hospital Pharmacists (EAHP)
European Society of Clinical Pharmacy (ESCP)
International Pharmaceutical Students' Federation (IPSF)
American Association of Colleges of Pharmacy (AACP)

6^th European virtual summit on
Pharmaceutical science

Quick Links

Theme: Healing the past with the future of Pharmaceutical science

Conference Information

Welcome Message

About Conference

Tracks

Market Analysis of Pharma